{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T10:08:53Z","timestamp":1789898933753,"version":"4.0.1"},"reference-count":47,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"14","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,4]]},"DOI":"10.1097\/md.0000000000000722","type":"journal-article","created":{"date-parts":[[2015,4,9]],"date-time":"2015-04-09T15:15:54Z","timestamp":1428592554000},"page":"e722","source":"Crossref","is-referenced-by-count":53,"title":["Value of Quantitative and Qualitative Analyses of Circulating Cell-Free DNA as Diagnostic Tools for Hepatocellular Carcinoma"],"prefix":"10.1097","volume":"94","author":[{"given":"Wenjun","family":"Liao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yilei","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Penglei","family":"Ge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huayu","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haifeng","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinting","family":"Sang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shouxian","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"issue":"Suppl","key":"R1-19-20210226","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1097\/MCG.0b013e3182872f29","article-title":"Epidemiology of hepatocellular carcinoma: consider the population.","volume":"47","author":"Mittal","year":"2013","journal-title":"J Clin Gastroenterol"},{"issue":"Suppl 3","key":"R2-19-20210226","first-page":"iii1","article-title":"British Society of G. Guidelines for the diagnosis and treatment of hepatocellular carcinoma (HCC) in adults.","volume":"52","author":"Ryder","year":"2003","journal-title":"Gut"},{"key":"R3-19-20210226","doi-asserted-by":"crossref","first-page":"225","DOI":"10.3322\/caac.20006","article-title":"Cancer statistics, 2009.","volume":"59","author":"Jemal","year":"2009","journal-title":"CA Cancer J Clin"},{"key":"R4-19-20210226","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/S1499-3872(14)60026-6","article-title":"Influence of hepatitis viruses on clinicopathological profiles and long-term outcome in patients undergoing surgery for hepatocellular carcinoma.","volume":"13","author":"Tanase","year":"2014","journal-title":"Hepatobil Pancreat Dis Int"},{"key":"R5-19-20210226","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1093\/jnci\/djk174","article-title":"Liver cancer biomarkers struggling to succeed.","volume":"99","author":"Benowitz","year":"2007","journal-title":"J Natl Cancer Inst"},{"key":"R6-19-20210226","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1038\/nrc3066","article-title":"Cell-free nucleic acids as biomarkers in cancer patients.","volume":"11","author":"Schwarzenbach","year":"2011","journal-title":"Nat Rev Cancer"},{"key":"R7-19-20210226","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1016\/j.cca.2010.07.032","article-title":"Cell-free DNA in the blood as a solid tumor biomarker - a critical appraisal of the literature.","volume":"411","author":"Jung","year":"2010","journal-title":"Clin Chim Acta"},{"key":"R8-19-20210226","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.ab.2012.06.018","article-title":"Mutation-based detection and monitoring of cell-free tumor DNA in peripheral blood of cancer patients.","volume":"433","author":"Benesova","year":"2013","journal-title":"Anal Biochem"},{"key":"R9-19-20210226","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.lungcan.2008.07.012","article-title":"Circulating plasma DNA as diagnostic biomarker in non-small cell lung cancer.","volume":"64","author":"Paci","year":"2009","journal-title":"Lung Cancer (Amsterdam, Netherlands)"},{"key":"R10-19-20210226","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/1471-2288-3-25","article-title":"The development of QUADAS: a tool for the quality assessment of studies of diagnostic accuracy included in systematic reviews.","volume":"3","author":"Whiting","year":"2003","journal-title":"BMC Med Res Methodol"},{"key":"R11-19-20210226","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1016\/S0895-4356(03)00177-X","article-title":"The diagnostic odds ratio: a single indicator of test performance.","volume":"56","author":"Glas","year":"2003","journal-title":"J Clin Epidemiol"},{"key":"R12-19-20210226","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1001\/jama.1994.03510330081039","article-title":"Users guides to the medical literature. III. How to use an article about a diagnostic test. B. What are the results and will they help me in caring for my patients The Evidence-Based Medicine Working Group.","volume":"271","author":"Jaeschke","year":"1994","journal-title":"JAMA"},{"key":"R13-19-20210226","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1016\/j.jclinepi.2005.02.022","article-title":"Bivariate analysis of sensitivity and specificity produces informative summary measures in diagnostic reviews.","volume":"58","author":"Reitsma","year":"2005","journal-title":"J Clin Epidemiol"},{"key":"R14-19-20210226","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1002\/sim.4780121403","article-title":"Combining independent studies of a diagnostic test into a summary ROC curve: data-analytic approaches and some additional considerations.","volume":"12","author":"Moses","year":"1993","journal-title":"Stat Med"},{"key":"R15-19-20210226","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1126\/science.3287615","article-title":"Measuring the accuracy of diagnostic systems.","volume":"240","author":"Swets","year":"1988","journal-title":"Science"},{"key":"R16-19-20210226","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1002\/sim.1099","article-title":"Properties of the summary receiver operating characteristic (SROC) curve for diagnostic test data.","volume":"21","author":"Walter","year":"2002","journal-title":"Stat Med"},{"key":"R17-19-20210226","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1002\/sim.1186","article-title":"Quantifying heterogeneity in a meta-analysis.","volume":"21","author":"Higgins","year":"2002","journal-title":"Stat Med"},{"key":"R18-19-20210226","first-page":"1559","article-title":"How should meta-regression analyses be undertaken and interpreted Stat M","volume":"21","author":"Thompson","year":"2002","journal-title":"ed"},{"key":"R19-19-20210226","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test.","volume":"315","author":"Egger","year":"1997","journal-title":"BMJ"},{"key":"R20-19-20210226","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1111\/j.0006-341X.2000.00455.x","article-title":"Trim and fill: a simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis.","volume":"56","author":"Duval","year":"2000","journal-title":"Biometrics"},{"key":"R21-19-20210226","first-page":"1057","article-title":"Circulating free DNA in the progression of liver damage to hepatocellular carcinoma.","volume":"1050-","author":"Piciocchi","year":"2013","journal-title":"Hepatol Int"},{"key":"R22-19-20210226","first-page":"4713","article-title":"Elevated levels of circulating cell-free DNA in the blood of patients with hepatitis C virus-associated hepatocellular carcinoma.","volume":"26","author":"Iizuka","year":"2006","journal-title":"Anticancer Res"},{"key":"R23-19-20210226","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1007\/s00432-005-0049-5","article-title":"The prognostic value of circulating plasma DNA level and its allelic imbalance on chromosome 8p in patients with hepatocellular carcinoma.","volume":"132","author":"Ren","year":"2006","journal-title":"J Cancer Res Clin Oncol"},{"key":"R24-19-20210226","doi-asserted-by":"crossref","first-page":"E238","DOI":"10.25011\/cim.v34i4.15366","article-title":"Quantification of plasma hTERT DNA in hepatocellular carcinoma patients by quantitative fluorescent polymerase chain reaction.","volume":"34","author":"Yang","year":"2011","journal-title":"Clin Invest Med"},{"key":"R25-19-20210226","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/s12253-011-9438-z","article-title":"Quantitation of plasma circulating DNA using quantitative PCR for the detection of hepatocellular carcinoma.","volume":"18","author":"Huang","year":"2012","journal-title":"Pathol Oncol Res"},{"key":"R26-19-20210226","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1097\/PAT.0b013e328353a24c","article-title":"Total serum DNA and DNA integrity: diagnostic value in patients with hepatitis B virus-related hepatocellular carcinoma.","volume":"44","author":"Chen","year":"2012","journal-title":"Pathology"},{"key":"R27-19-20210226","doi-asserted-by":"crossref","first-page":"3143","DOI":"10.3748\/wjg.v19.i20.3143","article-title":"Value of circulating cell-free DNA in diagnosis of hepatocelluar carcinoma.","volume":"19","author":"Chen","year":"2013","journal-title":"World J Gastroenterol"},{"key":"R28-19-20210226","doi-asserted-by":"crossref","first-page":"164","DOI":"10.7150\/ijms.6745","article-title":"Aberrant DNA methylation of G-protein-coupled bile acid receptor Gpbar1 (TGR5) is a potential biomarker for hepatitis B Virus associated hepatocellular carcinoma.","volume":"11","author":"Han","year":"2014","journal-title":"Int J Med Sci"},{"key":"R29-19-20210226","doi-asserted-by":"crossref","first-page":"83","DOI":"10.3346\/jkms.2004.19.1.83","article-title":"Detection of aberrant p16INK4A methylation in sera of patients with liver cirrhosis and hepatocellular carcinoma.","volume":"19","author":"Chu","year":"2004","journal-title":"J Korean Med Sci"},{"key":"R30-19-20210226","first-page":"1225","article-title":"Detection of promoter hypermethylation in serum samples of cancer patients by methylation-specific polymerase chain reaction for tumour suppressor genes including RUNX3.","volume":"18","author":"Tan","year":"2007","journal-title":"Oncol Rep"},{"key":"R31-19-20210226","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1007\/s10620-012-2462-3","article-title":"Detection of TFPI2 methylation in the serum of hepatocellular carcinoma patients.","volume":"58","author":"Sun","year":"2013","journal-title":"Digest Dis Sci"},{"key":"R32-19-20210226","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.cca.2010.09.028","article-title":"Efficient detection of hepatocellular carcinoma by a hybrid blood test of epigenetic and classical protein markers.","volume":"412","author":"Iizuka","year":"2011","journal-title":"Clin Chim Acta"},{"key":"R33-19-20210226","first-page":"11","article-title":"Evaluation of INK4A promoter methylation using pyrosequencing and circulating cell-free DNA from patients with hepatocellular carcinoma.","volume":"1-","author":"Huang","year":"2014","journal-title":"Clin Chem Lab Med"},{"key":"R35-19-20210226","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1111\/j.1478-3231.2005.01084.x","article-title":"High frequency of promoter hypermethylation of RASSF1A in tumor and plasma of patients with hepatocellular carcinoma.","volume":"25","author":"Yeo","year":"2005","journal-title":"Liver Int"},{"key":"R36-19-20210226","first-page":"111","article-title":"Is serum level of methylated RASSF1A valuable in diagnosing hepatocellular carcinoma in patients with chronic viral hepatitis C Arab J G","volume":"13","author":"Mohamed","year":"2012","journal-title":"astroenterol"},{"key":"R37-19-20210226","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1007\/s12072-013-9437-0","article-title":"Methylation profiling of serum DNA from hepatocellular carcinoma patients using an Infinium Human Methylation 450 BeadChip.","volume":"7","author":"Zhang","year":"2013","journal-title":"Hepatol Int"},{"key":"R38-19-20210226","doi-asserted-by":"crossref","first-page":"2378","DOI":"10.1158\/1078-0432.CCR-06-1900","article-title":"Predicting hepatocellular carcinoma by detection of aberrant promoter methylation in serum DNA.","volume":"13","author":"Zhang","year":"2007","journal-title":"Clin Cancer Res"},{"key":"R39-19-20210226","first-page":"1047","article-title":"Quantitative analysis of tumor-derived methylated p16INK4a sequences in plasma, serum, and blood cells of hepatocellular carcinoma patients.","volume":"9","author":"Wong","year":"2003","journal-title":"Clin Cancer Res"},{"key":"R40-19-20210226","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1093\/clinchem\/46.9.1420","article-title":"Relationship of p16 methylation status and serum alpha-fetoprotein concentration in hepatocellular carcinoma patients.","volume":"46","author":"Wong","year":"2000","journal-title":"Clin Chem"},{"key":"R41-19-20210226","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.yexmp.2008.07.001","article-title":"Methylation of tumor associated genes in tissue and plasma samples from liver disease patients.","volume":"85","author":"Chang","year":"2008","journal-title":"Exp Mol Pathol"},{"key":"R42-19-20210226","doi-asserted-by":"crossref","first-page":"4723","DOI":"10.3748\/wjg.v20.i16.4723","article-title":"MT1M and MT1G promoter methylation as biomarkers for hepatocellular carcinoma.","volume":"20","author":"Ji","year":"2014","journal-title":"World J Gastroenterol"},{"key":"R43-19-20210226","doi-asserted-by":"crossref","first-page":"18761","DOI":"10.1073\/pnas.1313995110","article-title":"Noninvasive detection of cancer-associated genome-wide hypomethylation and copy number aberrations by plasma DNA bisulfite sequencing.","volume":"110","author":"Chan","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R44-19-20210226","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1177\/172460081002500204","article-title":"Evaluation of serum DNA integrity as a screening and prognostic tool in patients with hepatitis C virus-related hepatocellular carcinoma.","volume":"25","author":"El-Shazly","year":"2010","journal-title":"Int J Biol Mark"},{"key":"R45-19-20210226","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1038\/sj.bjc.6600649","article-title":"Molecular diagnosis of primary liver cancer by microsatellite DNA analysis in the serum.","volume":"87","author":"Chang","year":"2002","journal-title":"Br J Cancer"},{"key":"R46-19-20210226","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/j.yexmp.2011.08.004","article-title":"Quantitative analysis of multiple methylated genes in plasma for the diagnosis and prognosis of hepatocellular carcinoma.","volume":"91","author":"Huang","year":"2011","journal-title":"Exp Mol Pathol"},{"key":"R47-19-20210226","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1373\/49.5.719","article-title":"Quantitative analysis of circulating mitochondrial DNA in plasma.","volume":"49","author":"Chiu","year":"2003","journal-title":"Clin Chem"},{"key":"R48-19-20210226","first-page":"524","article-title":"Diagnostic and prognostic role of alpha-fetoprotein in hepatocellular carcinoma: both or neither Am J G","volume":"101","author":"Farinati","year":"2006","journal-title":"astroenterol"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000000722","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T02:42:57Z","timestamp":1620960177000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00005792-201504020-00019"}},"subtitle":["A Meta-Analysis"],"short-title":[],"issued":{"date-parts":[[2015,4]]},"references-count":47,"journal-issue":{"issue":"14","published-print":{"date-parts":[[2015]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000000722","relation":{},"ISSN":["0025-7974"],"issn-type":[{"value":"0025-7974","type":"print"}],"subject":[],"published":{"date-parts":[[2015,4]]}}}